Name | Paltimatrectinib |
---|
Description | Paltimatrectinib (compound I-147) is a potent tyrosine kinase inhibitor with an IC50 of <10 nM for tropomyosin kinases A (TrkA). Paltimatrectinib has the potential for cancer and inflammatory diseases[1]. |
---|---|
Related Catalog | |
Target |
TrkA |
References |
Molecular Formula | C20H15F5N6 |
---|---|
Molecular Weight | 434.37 |